Exhibit 99.1

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS SECOND QUARTER & MIDYEAR 2022 RESULTS

Significant Demand Continues, Gross Margins Increase,

Midyear Net Income Doubles, Full Year Performance Targets Reiterated

Newport Beach, CA – August 9, 2022 – American Vanguard Corporation (NYSE: AVD) today announced financial results for the second quarter and six months ended June 30, 2022.

Fiscal 2022 Second Quarter Financial Highlights – versus Fiscal 2021 Second Quarter:

• Net sales were $148 million in 2022, compared to $135 million in 2021

• Net income was $6.8 million in 2022, compared to $5.1 million in 2021

• Earnings per diluted share of $0.23 in 2022, compared to $0.17 in 2021

• Adjusted EBITDA¹ of $19.7 million in 2022, compared to $16.5 million in 2021

Fiscal 2022 Mid-Year Financial Highlights – versus Fiscal 2021 Mid-Year:

• Net sales were $298 million in 2022, compared to $251 million in 2021

• Net income was $16.8 million in 2022, compared to $8.2 million in 2021

• Earnings per diluted share of $0.55 in 2022, compared to $0.27 in 2021

• Adjusted EBITDA¹ of $42.5 million in 2022, compared to $30.3 million in 2021

Eric Wintemute, Chairman and CEO of American Vanguard stated: “Conditions within our agricultural markets continue to be favorable with consistently high commodity prices, a strong farm economy and, for US-based companies, a strong US dollar. Having built a portfolio of products that reaches across multiple crops – including corn, soybeans, cotton, potatoes, and high-value fruits and vegetables – we were better able to cross-sell to growers and enjoyed strong demand for our products, both domestically and abroad. Our focused efforts to increase prices and more fully exploit our manufacturing assets enabled us to achieve higher margins despite inflation and supply chain challenges. Within this context, we recorded strong results for the second quarter and first half of 2022, including higher sales and improved profitability.”

Mr. Wintemute continued: “Our second quarter improvement was led by our international business, which generated higher sales of soil fumigants, foliar and soil insecticides, fungicides and micronutrient products across multiple regions. Our domestic crop business enjoyed strong demand for our expanding portfolio of herbicides, partially offset by lower soil fumigant sales due to drought conditions in the West and Southwest, where water allocation has been implemented. During the second quarter of 2022, our U.S. non-crop business experienced relatively steady demand in mosquito control, commercial pest applications and horticulture/ornamental products.”

¹  Adjusted earnings before interest, taxes, depreciation, amortization, non-cash stock compensation, and proxy contest activities. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from Adjusted EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define Adjusted EBITDA differently.

Mr. Wintemute concluded: “Looking forward, we believe that our Company is situated well in both domestic and international markets and are consequently optimistic, even with weather- and economy-related variables, about meeting or exceeding our previously announced performance targets for FY 2022, including revenue growth between 8% and 11%, gross profit margins of 38-40% of net sales, operating expenses within the range of 31-33% of net sales and a year-over-year net income increase of between 60% and 70%. We look forward to giving you a more detailed presentation during our upcoming earnings call.”

Conference Call

Eric Wintemute, Chairman & CEO, Bob Trogele, EVP & COO and David T. Johnson, VP & CFO, will conduct a conference call focusing on the financial results and strategic themes…at 4:30 pm ET on August 9, 2022. Interested parties may participate in the call by dialing 201-493-6744. Please call in 10 minutes before the call is scheduled to begin and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000^® and Russell 3000^® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

Company Contact:		Investor Representative
American Vanguard Corporation		the Equity Group Inc.
William A. Kuser, Director of Investor Relations		www.theequitygroup.com
(949) 260-1200		Lena Cati
williamk@amvac-chemical.com		Lcati@equityny.com

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

		June 30, 2022				December 31, 2021
ASSETS
Current assets:
Cash and cash equivalents		$	22,057			$	16,285
Receivables:
Trade, net of allowance for doubtful accounts of $4,411 and $3,938, respectively			165,711				149,326
Other			13,208				9,595
Total receivables, net			178,919				158,921
Inventories			182,203				154,306
Prepaid expenses			16,368				12,488
Income taxes receivable			523				—
Total current assets			400,070				342,000
Property, plant and equipment, net			67,453				66,111
Operating lease right-of-use assets			24,449				25,386
Intangible assets, net			191,560				197,841
Goodwill			46,997				46,260
Other assets			13,099				16,292
Deferred income tax assets, net			16				270
Total assets		$	743,644			$	694,160
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current installments of other liabilities		$	1,367			$	802
Accounts payable			86,944				67,140
Customer prepayments			272				63,064
Accrued program costs			99,152				63,245
Accrued expenses and other payables			20,180				20,745
Income taxes payable			—				3,006
Current operating lease liabilities			5,029				5,059
Total current liabilities			212,944				223,061
Long-term debt, net			100,779				52,240
Long-term operating lease liabilities			19,852				20,780
Other liabilities, net of current installments			5,584				5,335
Deferred income tax liabilities, net			19,651				20,006
Total liabilities			358,810				321,422
Commitments and contingent liabilities
Stockholders’ equity:
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued			—				—
Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 34,443,234 shares at June 30, 2022 and 34,248,218 shares at December 31, 2021			3,445				3,426
Additional paid-in capital			103,456				101,450
Accumulated other comprehensive loss			(12,768	)			(13,784	)
Retained earnings			319,672				304,385
Less treasury stock at cost, 3,694,050 shares at June 30, 2022 and 3,361,040 shares at December 31, 2021			(28,971	)			(22,739	)
Total stockholders’ equity			384,834				372,738
Total liabilities and stockholders’ equity		$	743,644			$	694,160

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

		For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2022				2021				2022				2021
Net sales		$	148,084			$	134,610			$	297,519			$	250,765
Cost of sales			(88,305	)			(82,471	)			(176,547	)			(153,495	)
Gross profit			59,779				52,139				120,972				97,270
Operating expenses			(48,966	)			(43,080	)			(95,410	)			(84,524	)
Adjustment to bargain purchase gain on business acquisition			—				(88	)			—				(121	)
Operating income			10,813				8,971				25,562				12,625
Change in fair value of an equity investment			(486	)			(295	)			(403	)			771
Other income			—				—				—				672
Interest expense, net			(772	)			(1,013	)			(1,170	)			(1,959	)
Income before provision for income taxes and loss on equity method investment			9,555				7,663				23,989				12,109
Income tax expense			(2,725	)			(2,445	)			(7,224	)			(3,807	)
Income before loss on equity method investment			6,830				5,218				16,765				8,302
Loss on equity method investment			—				(74	)			—				(87	)
Net income		$	6,830			$	5,144			$	16,765			$	8,215
Earnings per common share—basic		$	.23			$	.17			$	.57			$	.28
Earnings per common share—assuming dilution		$	.23			$	.17			$	.55			$	.27
Weighted average shares outstanding—basic			29,602				29,930				29,639				29,834
Weighted average shares outstanding—assuming dilution			30,225				30,499				30,289				30,511

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

ANALYSIS OF SALES

(In thousands)

(Unaudited)

		For the three months ended June 30,
		2022				2021				Change				% Change
Net sales:
U.S. crop		$	63,195			$	62,575			$	620				1	%
U.S. non-crop			21,316				21,488				(172	)			-1	%
U.S. total			84,511				84,063				448				1	%
International			63,573				50,547				13,026				26	%
Net sales:		$	148,084			$	134,610			$	13,474				10	%
Gross profit:
U.S. crop		$	29,753			$	26,805			$	2,948				11	%
U.S. non-crop			10,049				9,782				267				3	%
U.S. total			39,802				36,587				3,215				9	%
International			19,977				15,552				4,425				28	%
Total gross profit:		$	59,779			$	52,139			$	7,640				15	%

		For the six months ended June 30,
		2022				2021				Change				% Change
Net sales:
U.S. crop		$	151,388			$	117,330			$	34,058				29	%
U.S. non-crop			34,712				38,941				(4,229	)			-11	%
U.S. total			186,100				156,271				29,829				19	%
International			111,419				94,494				16,925				18	%
Net sales:		$	297,519			$	250,765			$	46,754				19	%
Gross profit:
U.S. crop		$	70,098			$	48,076			$	22,022				46	%
U.S. non-crop			16,014				19,165				(3,151	)			-16	%
U.S. total			86,112				67,241				18,871				28	%
International			34,860				30,029				4,831				16	%
Total gross profit:		$	120,972			$	97,270			$	23,702				24	%

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

		For the Six Months Ended June 30,
		2022				2021
Cash flows from operating activities:
Net income		$	16,765			$	8,215
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization of property, plant and equipment and intangible assets			11,004				10,697
Amortization of other long-term assets			1,739				2,044
Loss on disposal of property, plant and equipment			256				—
Accretion of discounted liabilities			17				(11	)
Amortization of deferred loan fees			139				162
Provision for bad debts			470				945
Loan principal and interest forgiveness			—				(672	)
Fair value adjustment to contingent consideration			635				1,013
Stock-based compensation			2,836				3,598
Change in deferred income taxes			109				(353	)
Change in fair value of an equity investment			403				(771	)
Loss on equity method investment			—				87
Adjustment to bargain purchase gain on business acquisition			—				121
Net foreign currency adjustments			(20	)			(145	)
Changes in assets and liabilities associated with operations:
Increase in net receivables			(18,645	)			(25,317	)
Increase in inventories			(27,774	)			(11,464	)
Increase in prepaid expenses and other assets			(3,652	)			(3,696	)
(Increase) decrease in income tax receivable/payable, net			(3,526	)			1,374
(Decrease) in net operating lease liability			(21	)			(120	)
Increase in accounts payable			19,439				6,190
Decrease in customer prepayments			(62,789	)			(30,407	)
Increase in accrued program costs			35,987				19,098
(Decrease) increase in other payables and accrued expenses			(602	)			507
Net cash used in operating activities			(27,230	)			(18,905	)
Cash flows from investing activities:
Capital expenditures			(5,654	)			(5,075	)
Proceeds from disposal of property, plant and equipment			27				—
Acquisition of product line			—				(10,000	)
Intangible assets			(1,044	)			(241	)
Investments			—				(184	)
Net cash used in investing activities			(6,671	)			(15,500	)
Cash flows from financing activities:
Payments under line of credit agreement			(56,600	)			(24,226	)
Borrowings under line of credit agreement			105,000				66,000
Payment of contingent consideration			—				(250	)
Net receipt from the issuance of common stock under ESPP			436				340
Net receipt from the exercise of stock options			765				167
Payment for tax withholding on stock-based compensation awards			(2,012	)			(2,900	)
Repurchase of common stock			(6,232	)			—
Payment of cash dividends			(1,330	)			(1,188	)
Net cash provided by financing activities			40,027				37,943
Net increase in cash and cash equivalents			6,126				3,538
Effect of exchange rate changes on cash and cash equivalents			(354	)			98
Cash and cash equivalents at beginning of period			16,285				15,923
Cash and cash equivalents at end of period		$	22,057			$	19,559

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

UNAUDITED RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA

(Unaudited)

		Three Months Ended June 30,								Six Months Ended June 30,
		2022				2021				2022				2021
Net income, as reported		$	6,830			$	5,144			$	16,765			$	8,215
Provision for income taxes			2,725				2,445				7,224				3,807
Interest expense, net			772				1,013				1,170				1,959
Depreciation and amortization			6,271				6,138				12,743				12,741
Stock compensation			1,273				1,806				2,836				3,598
Proxy contest activities			1,785				—				1,785				—
Adjusted EBITDA2		$	19,656			$	16,546			$	42,523			$	30,320

²  Adjusted earnings before interest, taxes, depreciation, amortization, non-cash stock compensation, and proxy contest activities. Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measures so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. We provide these measures because we believe that they provide helpful comparisons to other companies in our industry and peer group. The items excluded from Adjusted EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define Adjusted EBITDA differently.